- Home
- SSRM vs ARVN Comparison
SSRM vs ARVN Comparison
Compare SSRM & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSRM
- ARVN
- Stock Information
- Founded
- SSRM 1946
- ARVN 2015
- Country
- SSRM United States
- ARVN United States
- Employees
- SSRM N/A
- ARVN N/A
- Industry
- SSRM Precious Metals
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- SSRM Industrials
- ARVN Health Care
- Exchange
- SSRM Nasdaq
- ARVN Nasdaq
- Market Cap
- SSRM 1.5B
- ARVN 1.4B
- IPO Year
- SSRM 1996
- ARVN 2018
- Fundamental
- Price
- SSRM $7.84
- ARVN $18.57
- Analyst Decision
- SSRM Hold
- ARVN Strong Buy
- Analyst Count
- SSRM 3
- ARVN 13
- Target Price
- SSRM $5.18
- ARVN $63.00
- AVG Volume (30 Days)
- SSRM 2.9M
- ARVN 860.7K
- Earning Date
- SSRM 02-19-2025
- ARVN 02-25-2025
- Dividend Yield
- SSRM N/A
- ARVN N/A
- EPS Growth
- SSRM N/A
- ARVN N/A
- EPS
- SSRM N/A
- ARVN N/A
- Revenue
- SSRM $1,098,328,000.00
- ARVN $161,100,000.00
- Revenue This Year
- SSRM N/A
- ARVN $239.85
- Revenue Next Year
- SSRM $20.56
- ARVN N/A
- P/E Ratio
- SSRM N/A
- ARVN N/A
- Revenue Growth
- SSRM N/A
- ARVN 1.07
- 52 Week Low
- SSRM $3.76
- ARVN $17.08
- 52 Week High
- SSRM $9.99
- ARVN $53.08
- Technical
- Relative Strength Index (RSI)
- SSRM 65.11
- ARVN 43.53
- Support Level
- SSRM $7.03
- ARVN $17.35
- Resistance Level
- SSRM $7.79
- ARVN $21.00
- Average True Range (ATR)
- SSRM 0.28
- ARVN 1.18
- MACD
- SSRM 0.03
- ARVN 0.12
- Stochastic Oscillator
- SSRM 89.74
- ARVN 38.01
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.